Approval · Notice of Compliance 27052 · 2021
M-FINASTERIDE: Notice of Compliance 27052
Issued November 18, 2021
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 27052
- Date
- November 18, 2021
- Company
- Mantra Pharma Inc.Brossard, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- Administrative: Licensing Agreement Between Two Companies
- Canadian reference product
- PROSCAR (Merck Frosst Canada Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| M-FINASTERIDE | 02522489 | Dormant |
Medicinal ingredients
- FINASTERIDE 5 MG per TAB